The market size for Penicillins and Streptomycins in France has shown fluctuations from 2013 to 2023, ending at 717.2 million USD in 2023. An initial decline was observed from 2013 to 2015, followed by a period of moderate recovery and stabilization. The market witnessed growth in 2018 and 2020, with significant contractions in other years, particularly in 2015. Year-over-year variations highlight inconsistent trends, while the five-year CAGR reveals a near-stable trend between 2018 and 2023.
Future trends to watch for:
- Potential growth driven by the increased demand for antibiotics post-pandemic.
- Impact of regulations and competition from generic alternatives.
- Technological advancements in antibiotic formulation and delivery.
How does France rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
